Goldman Sachs Group Inc Insmed Inc Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Insmed Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,393,049 shares of INSM stock, worth $92.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,393,049

Previous 1,189,901 17.07%

Holding current value

$92.3 Million

Previous $79.7 Million 27.56%

% of portfolio

0.02%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$62.0 - $79.01 $12.6 Million - $16.1 Million	203,148 Added 17.07%	1,393,049 $102 Million
Q2 2024 Aug 13, 2024	BUY	$22.0 - $69.71 $9.6 Million - $30.4 Million	436,291 Added 57.89%	1,189,901 $79.7 Million
Q1 2024 May 15, 2024	SELL	$25.72 - $29.94 $209,926 - $244,370	-8,162 Reduced 1.07%	753,610 $20.4 Million
Q4 2023 Feb 13, 2024	SELL	$23.42 - $31.74 $2.38 Million - $3.23 Million	-101,746 Reduced 11.78%	761,772 $23.6 Million
Q3 2023 May 14, 2024	BUY	$19.86 - $26.93 $2.02 Million - $2.74 Million	101,746 Added 13.36%	863,518 $21.8 Million
Q3 2023 Nov 14, 2023	BUY	$19.86 - $26.93 $1.39 Million - $1.88 Million	69,834 Added 8.8%	863,518 $21.8 Million
Q2 2023 May 14, 2024	BUY	$16.44 - $21.1 $3.81 Million - $4.89 Million	231,888 Added 41.28%	793,684 $16.7 Million
Q2 2023 Aug 14, 2023	BUY	$16.44 - $21.1 $3.81 Million - $4.89 Million	231,888 Added 41.28%	793,684 $16.7 Million
Q1 2023 May 14, 2024	SELL	$16.26 - $21.73 $7.63 Million - $10.2 Million	-469,100 Reduced 45.5%	561,796 $9.58 Million
Q1 2023 May 11, 2023	SELL	$16.26 - $21.73 $7.63 Million - $10.2 Million	-469,100 Reduced 45.5%	561,796 $9.58 Million
Q4 2022 May 14, 2024	BUY	$16.98 - $23.15 $2.71 Million - $3.7 Million	159,719 Added 18.33%	1,030,896 $20.6 Million
Q4 2022 Feb 13, 2023	BUY	$16.98 - $23.15 $2.71 Million - $3.7 Million	159,719 Added 18.33%	1,030,896 $20.6 Million
Q3 2022 May 14, 2024	BUY	$20.88 - $28.21 $8.41 Million - $11.4 Million	402,677 Added 85.95%	871,177 $18.8 Million
Q3 2022 Nov 10, 2022	BUY	$20.88 - $28.21 $8.41 Million - $11.4 Million	402,677 Added 85.95%	871,177 $18.8 Million
Q2 2022 May 14, 2024	SELL	$17.07 - $25.71 $5.01 Million - $7.54 Million	-293,272 Reduced 38.5%	468,500 $9.24 Million
Q2 2022 Aug 15, 2022	SELL	$17.07 - $25.71 $1.51 Million - $2.27 Million	-88,478 Reduced 15.89%	468,500 $9.24 Million
Q1 2022 May 16, 2022	BUY	$20.42 - $28.13 $1.91 Million - $2.63 Million	93,652 Added 20.21%	556,978 $13.1 Million
Q4 2021 Feb 14, 2022	BUY	$25.89 - $33.45 $5.73 Million - $7.4 Million	221,138 Added 91.31%	463,326 $12.6 Million
Q3 2021 Nov 10, 2021	BUY	$22.46 - $29.47 $5.44 Million - $7.14 Million	242,188 New	242,188 $6.67 Million

Others Institutions Holding INSM

# of Institutions

465

Shares Held

182M

Call Options Held

2.27M

Put Options Held

3.33M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $8.98B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Insmed Inc Transaction History